when did glp 1 drugs come out History of glucagon-like peptide-1 receptor agonists GLP-1 Agonists: Using Semaglutide, Tirzepatide,

GLP-1 Data Survey 2025: GLP-1 Weight Loss, Types of GLP-1 Used, GLP-1 Duration Usage, GLP-1 Side Effects, Satisfaction & more.

Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.

Gastrointestinal side effects are a little more common in the oral version than in the injectables

Compare how they work, their prices, and more.

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users